Search Results 391-400 of 16256 for pharmacogenetics
The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
The median survival is about 5 months from time of diagnosis. A Mayo Clinic-led study, published in the journal Science Translational Medicine , reveals the ...
Research curriculum for the PGY-1 Pharmacy Residency at Mayo Clinic Health System — Eau Claire, Wisconsin within Mayo Clinic School of Health Sciences.
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Chronic diseases are on the rise. Many have no easy treatment, some none at all. "As a medical institution, we won't accept that the current state of ...
The purpose of this study is is to assess the EPIQ-Affiniti and NG Compact ultrasound systems in a clinical environment and collect clinical data and feedback ...
The Somatic Mutations in Development and Aging Lab of Alexej Abyzov, Ph.D., at Mayo Clinic studies the effects of DNA changes that happen during a person's ...
The purpose of this study is to identify common genetic variants contributing to the risk of glioma. Evaluate gene-gene and gene-environmental interactions with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.